for Biologics Research
Genedata Biologics® is a modular, scalable, and integrated platform providing out-of-the-box support for biopharma research workflows. It allows flexible configuration for customer-specific workflows such as proprietary cloning strategies, antibody formats, or custom laboratory protocols.
Genedata Biologics was the obvious choice because collaborating with CROs is a key part of our strategy, so we require an open and scalable system able to capture and integrate all data generated by our CRO network.
Tim Holmström, Ph.D.
Head of Biologics
The new Request Management System has made our overall biologics R&D process much more efficient—intergroup communication is now standardized, streamlined and traceable, and there is much less ad hoc communication.
Miguel Teodoro, Ph.D.
Head of IT Research
As an established, off-the-shelf product, Genedata Biologics could be deployed across our organization with minimal customization.
Genedata Biologics provides a modular and scalable platform supporting complex R&D workflows in a division-of-labor environment.
Senior Director of R&D Informatics
We required a scalable software solution that is compatible with Immatics’ proprietary XCEPTOR platform to facilitate the systematic analysis of our TCR data for our proprietary and partnered programs.
Dominik Maurer, Ph.D.
The Genedata solution is now an integral part of our R&D infrastructure, supporting our efforts to develop novel biopharmaceuticals for hard-to-drug therapeutic targets.
Aaron Sato, Ph.D.
Chief Scientific Officer
The Biologics Data Platform supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process.
Clive Wood, Ph.D.
Head of Global Biologics
Genedata Biologics’ flexibility allows Pfizer to configure the system to address both proprietary discovery processes as well as Pfizer-specific business processes and nomenclature.
Sergio Rotstein, Ph.D.
Director of Research Business Technology
We liked that Genedata Biologics can be easily set-up to work with Teva’s workflows and technologies and that it’s an open system that can be integrated in Teva’s existing R&D and IT environment. Finally, we appreciate that the system is extendable and will scale with us as we grow.
Adam Clarke, Ph.D.
Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process—right through from the immunization of transgenic mice, to lead selection, molecular modification and final candidate assessments.
Thomas Sandal, Ph.D.
Vice President, R&D
We are pleased to see the steady and continuous evolution of the Genedata Biologics platform and how it addresses our consistently emerging new technology and workflow requirements.
Markus Enzelberger, Ph.D.
Senior VP and Head of Discovery, Alliances and Technologies
Genedata Biologics provides a flexible architecture and includes built-in biopharma domain knowledge, which can handle our proprietary bispecific antibody discovery processes.
Neil Brewis, Ph.D.
We are rapidly expanding our biotherapeutic R&D activities and needed a scalable, flexible platform that we could quickly and easily implement. We chose Genedata Biologics as it is the only out-of-the-box platform on the market dedicated to large-molecule R&D.
Bjoern Hock, Ph.D.
Director, Global Head Protein Engineering and Antibody Technologies
Genedata Biologics is the leading workflow platform for high-throughput antibody discovery. The platform’s open architecture allows us to flexibly configure the system to work with Kymab’s proprietary workflows and technologies, including our transgenic mouse platform.
Glenn A. Friedrich, Ph.D.
Chief Operating Officer
Scalability That Works.
Biopharma companies big and small streamline and simplify their biotherapeutic research processes using the Genedata Biologics data backbone. All users have real-time access to all relevant information—nothing is buried in an inbox or lost on an Excel spreadsheet. Users report more than 50% gains in efficiency and throughput as well as improved quality of results.
Up & Running. On Day One.
As true commercial off-the-shelf software (COTS), Genedata Biologics is ready to go right after installation. All workflow-relevant business logic, such as phage and yeast display, hybridoma, B cell screening, molecular biology, expression, purification, analytics, QC, and candidate developability assessment, is built into the platform and immediately available. No painful and costly template development is needed—out-of-the-box, the platform can be rolled out to the organization.
Connect. Upgrade. Build on Top.
Genedata Biologics is an open system that seamlessly integrates with any IT environment via its easy-to-use APIs. RESTful Webservices ensure a safe, transparent and high-performing integration with any corporate IT environment. The open system architecture allows for simple yet flexible integration with corporate IT systems, to address customer-specific integration requirements.
Data Exchange. Made Easy.
In biopharma R&D, virtually all data is produced by laboratory instruments, including assay and analytics data from ELISA, SPR, FACS, or FMAT, or DNA and protein sequences based on NGS and other sequencing technologies. Genedata Biologics seamlessly integrates with all laboratory instruments and automatically captures and transfers instrument data. It minimizes or eliminates manual data entry such as one-directional data capture from assay readers or bi-directional integration with liquid handling robots. Our dedicated Ready-to-Run™ program ensures that the platform can be seamlessly plugged into any major laboratory instruments on the market.